Actemra 400 mg injection
Actema 400mg injection
Tocilizumab (400mg)
Actemra 4oomg is medicine used to treat various inflammation Condition of the joints (the arthritis proriatic arthritis, ankylosing SpondyLitis skin and bowel Culcerative Colitis, crohn's disease). It reduces swelling in these Condlitions by blocking TNF alpha.
Cipla Actemra Tocilizumab Injection 400 mg
Product SpecificationPackaging Size 1 Vial of 20 mlStrength 400 mgTreatment COVID-19Prescription/Non prescription PrescriptionBrand ActemraManufacturer Cipla LtdForm Injection
ACTEMRA can cause serious side effects, including:
feel very tired
vomiting
chills
dark urine
skin or eyes look yellow
clay-colored bowel movements
stomach discomfort
skin rash
little or no appetite
fevers
muscle aches
-:WARNING:-
RISK OF SERIOUS INFECTIONS Patients treated with ACTEMRA are at increased risk for developing serious infections that may lead to hospitalization or death
The risks and benefits of treatment with ACTEMRA should be carefully considered prior to initiating therapy in patients with chronic or recurrent infection. Patients should be closely monitored for the development of signs and symptoms of infection during and after treatment with ACTEMRA, including the possible development of tuberculosis in patients who tested negative for latent tuberculosis infection prior to initiating therapy [see WARNINGS AND PRECAUTIONS].
Comments